Merck's new formulation could help secure a larger share of Keytruda's sales after the cancer drug's U.S. patent expires in ...

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Danish pharmaceutical company Novo Nordisk announced last weekend that Wegovy, the weight-loss version of the company's ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

NEW YORK (PIX11) — If you’ve noticed ads for weight loss injections flood your social media feeds ... 1 medications for ...

A HEALTHCARE worker has told show she almost died after fat loss jabs she ordered from Facebook were feared to have been ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

A new study has found that Mounjaro may not only be good at treating diabetes, but could actually help prevent the disease.

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Key Takeaways Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's ...